Activation of TLR‐4 to produce tumour necrosis factor‐α in neuropathic pain caused by paclitaxel

Z Wu, S Wang, I Wu, M Mata… - European journal of pain, 2015 - Wiley Online Library
Background Neuropathic pain is a common complication of treatment with the anti‐
neoplastic drug paclitaxel. Animal studies suggest neuroinflammation and transient receptor …
被引用次数：68 相关文章

Activation of TLR-4 to produce tumour necrosis factor-α in neuropathic pain caused by paclitaxel.

Z Wu, S Wang, I Wu, M Mata, DJ Fink - European Journal of Pain …, 2014 - europepmc.org
Background Neuropathic pain is a common complication of treatment with the anti-
neoplastic drug paclitaxel. Animal studies suggest neuroinflammation and transient receptor …

Activation of TLR‐4 to produce tumour necrosis factor‐α in neuropathic pain caused by paclitaxel

Z Wu, S Wang, I Wu, M Mata, DJ Fink - European Journal of Pain, 2015 - infona.pl
Background Neuropathic pain is a common complication of treatment with the anti‐
neoplastic drug paclitaxel. Animal studies suggest neuroinflammation and transient receptor …

Activation of TLR-4 to produce tumour necrosis factor-α in neuropathic pain caused by paclitaxel

Z Wu, S Wang, I Wu, M Mata… - European journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Neuropathic pain is a common complication of treatment with the anti-
neoplastic drug paclitaxel. Animal studies suggest neuroinflammation and transient receptor …

Activation of TLR‐4 to produce tumour necrosis factor‐α in neuropathic pain caused by paclitaxel

Z Wu, S Wang, I Wu, M Mata, DJ Fink - 2015 - deepblue.lib.umich.edu
BackgroundNeuropathic pain is a common complication of treatment with the anti‐
neoplastic drug paclitaxel. Animal studies suggest neuroinflammation and transient receptor …